John T
Immunoscience R&D
Bay Zoltan Nonprofit Public Ltd. for Applied Research
Philippines
Biography
John is responsible for leading the development of assets in our Immunoscience pipeline. John is accountable for developing and implementing the drug development strategy across all phases of development from Phase 1 through registration and life cycle management. John joined Bristol-Myers Squibb in 2014 following 15 years at GlaxoSmithKline (GSK), where he most recently was Head of Operations and Strategy for the Immuno-inflammation and Infectious Diseases franchise. Prior to that role, John led the development of selected early stage assets and partnered with biotech companies to bring early stage assets into GSK.
Research Interest
Immunoscience
